Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies

被引：1
|
作者：
Upadhayaya, Ram S. [1 ]
Kethiri, Raghava Reddy [1 ]
Vellanki, Avanish [2 ]
Lightfoot, Jeff [3 ]
Local, Andrea [4 ]
Rice, William G. [4 ]
机构：
[1] Laxai Avanti Life Sci, Hyderabad, Andhra Pradesh, India
[2] Aptose Biosci Inc, Redwood City, CA USA
[3] Aptose Biosci Inc, Mississauga, ON, Canada
[4] Aptose Biosci Inc, San Diego, CA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5212.5212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5212
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
    Li, Junhua
    Hu, Qingqing
    Zhu, Run
    Dong, Ruibo
    Shen, Hui
    Hu, Jiankang
    Zhang, Cheng
    Zhang, Xiaohan
    Xu, Tingting
    Xiang, Qiuping
    Zhang, Yan
    Lin, Bin
    Zhao, Linxiang
    Wu, Xishan
    Xu, Yong
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 21577 - 21616
  • [2] Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
    Chen, Jingjing
    Li, Yalei
    Zhang, Jie
    Zhang, Minmin
    Wei, Aihuan
    Liu, Hongchun
    Xie, Zhicheng
    Ren, Wenming
    Duan, Wenwen
    Zhang, Zhuo
    Shen, Aijun
    Hu, Youhong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
  • [3] Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies
    Jiang, Fei
    Wei, Qingyun
    Li, Huili
    Li, Hongmei
    Cui, Yong
    Ma, Yu
    Chen, Haifang
    Cao, Peng
    Lu, Tao
    Chen, Yadong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (01)
  • [4] JAK2 inhibition for the treatment of hematologic and solid malignancies
    Harry, Brian L.
    Eckhardt, S. Gail
    Jimeno, Antonio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (05) : 637 - 655
  • [5] Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
    Zengerle, Michael
    Chan, Kwok-Ho
    Ciulli, Alessio
    ACS CHEMICAL BIOLOGY, 2015, 10 (08) : 1770 - 1777
  • [6] Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking
    Zhao, Hongtao
    Gartenmann, Lisa
    Dong, Jing
    Spiliotopoulos, Dimitrios
    Caflisch, Amedeo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (11) : 2493 - 2496
  • [7] Jak2 Inhibitors: Rationale and Role as Therapeutic Agents in Hematologic Malignancies
    Sayyah, Jacqueline
    Sayeski, Peter P.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (02) : 117 - 124
  • [8] Straightforward hit identification approach in fragment-based discovery of bromodomain-containing protein 4 (BRD4) inhibitors
    Borysko, Petro
    Moroz, Yurii S.
    Vasylchenko, Oleksandr V.
    Hurmach, Vasyl V.
    Starodubtseva, Anastasia
    Stefanishena, Natalia
    Nesteruk, Kateryna
    Zozulya, Sergey
    Kondratov, Ivan S.
    Grygorenko, Oleksandr O.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (12) : 3399 - 3405
  • [9] Jak2 inhibitors: Rationale and role as therapeutic agents in hematologic malignancies
    Jacqueline Sayyah
    Peter P. Sayeski
    Current Oncology Reports, 2009, 11 : 117 - 124
  • [10] Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain
    Zhao, Lele
    Cao, Danyan
    Chen, Tiantian
    Wang, Yingqing
    Miao, Zehong
    Xu, Yechun
    Chen, Wuyan
    Wang, Xin
    Li, Yardian
    Du, Zhiyan
    Xiong, Bing
    Li, Jian
    Xu, Chunyan
    Zhang, Naixia
    He, Jianhua
    Shen, Jingkang
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (10) : 3833 - 3851
12345